Screening of donor and recipient prior to solid organ transplantation

American Journal of Transplantation

Volumn 4, Issue 10 SUPPL., 2004, Pages 10-20

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANAMNESIS; DISEASE SEVERITY; DISEASE TRANSMISSION; HUMAN; INFECTION RISK; LIVING DONOR; ORGAN TRANSPLANTATION; POSTOPERATIVE INFECTION; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; SERODIAGNOSIS; VACCINATION; BACTERIAL INFECTION; DONOR; MYCOSIS; PHYSIOLOGY; STATISTICS; TRANSPLANTATION; VIRUS INFECTION;

BACTERIAL INFECTIONS; HUMANS; LIVING DONORS; MYCOSES; TISSUE DONORS; TRANSPLANTATION; VIRUS DISEASES;

EID: 16644377738     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6135.2004.00616.x     Document Type: Review

References (92)

1. Gottesdiener KM. Transplanted infections: donor-to-host transmission with the allograft. Ann Intern Med 1989; 110: 1001-1016.
2. Rubin R. Infection in organ transplant recipients. In: RH Rubin. LS Young., eds. Clinical Approach to Infection in the Compromised Host, 4th edn. New York and London: Plenum 2002.
3. Schaffner A. Pretransplant evaluation for infections in donors and recipients of solid organs. Clin Infect Dis 2001; 33 (Suppl. 1): S9-S14.
4. Avery RK, Ljungman P. Prophylactic measures in the solid-organ recipient before transplantation. Clin Infect Dis 2001; 33 (Suppl. 1): S15-S21.
5. Delmonico FL, Snydman DR. Organ donor screening for infectious diseases: review of practice and implications for transplantation. Transplantation 1998; 65: 603-610.
6. Delmonico FL. Cadaver donor screening for infectious agents in solid organ transplantation. Clin Infect Dis 2000; 31: 781-786.
7. Avery RK. Recipient screening prior to solid-organ transplantation. Clin Infect Dis 2002; 35: 1513-1519.
8. Kasiske BL, Cangro CB, Hariharan S et al. for the American Society of Transplantation. The evaluation of renal transplant candidates: clinical practice guidelines. Am J Transplant 2002. 2 (Suppl. 1), 5-95.
9. Kasiske BL, Ravenscraft M, Ramos EL, Gaston RS, Bia MJ, Danovitch GM. The evaluation of living renal transplant donors: clinical practice guidelines. Ad Hoc Clinical Practice Guidelines Subcommittee of the Patient Care and Education Committee of the American Society of Transplant Physicians. J Am Soc Nephrol 1996; 7: 2288-2313.
10. Rosengard BR, Feng S, Alfrey EJ et al. Report of the Crystal City Meeting to Maximize the Use of Organs Recovered from the Cadaver Donor. Am J Transplant 2002; 2: 701-711.
11. Chung RT, Feng S, Delmonico FL. Approach to the management of allograft recipients following the detection of hepatitis B virus in the prospective organ donor. Am J Transplant 2001; 1: 185-191.
12. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. MMWR Morb Mortal Wkly Report 2000; 49: 1-125.
13. Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Report 1994; 43: 1-17.
14. Simonds RJ, Holmberg SD, Hurwitz RL et al. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med 1992; 326: 726-732.
15. Freeman RB, Giatras I, Falagas ME et al. Outcome of transplantation of organs procured from bacteremic donors. Transplantation 1999; 68: 1107-1111.
16. Mossad SB, Avery RK, Goormastic M, Hobbs RE, Stewart RW. Significance of positive cultures from donor left atrium and post-preservation fluid in heart transplantation. Transplantation 1997; 64: 1209-1210.
17. Gibel LJ, Sterling W, Hoy W, Harford A. Is serological evidence of infection with syphilis a contraindication to kidney donation? Case report and review of the literature. J Urol 1987; 138: 1226-1227.
18. Caballero F, Domingo P, Rabella N, Lopez-Navidad A. Successful transplantation of organs retrieved from a donor with syphilis. Transplantation 1998; 65: 598-599.
19. McCoy GC, Loening S, Braun WE, Magnusson MO, Banowsky LH, McHenry MC. The fate of cadaver renal allografts contaminated before transplantation. Transplantation 1975; 20: 467-472.
20. Doig RL, Boyd PJ, Eykyn S. Staphylococcus aureus transmitted in transplanted kidneys. Lancet 1975; 2: 243-245.
21. Nelson PW, Delmonico FL, Tolkoff-Rubin NE et al. Unsuspected donor pseudomonas infection causing arterial disruption after renal transplantation. Transplantation 1984; 37: 313-314.
22. Fernando ON, Higgins AF, Moorhead JF. Letter: Secondary haemorrhage after renal transplantation. Lancet 1976; 2: 368.
23. Lopez-Navidad A, Domingo P, Caballero F, Gonzalez C, Santiago C. Successful transplantation of organs retrieved from donors with bacterial meningitis. Transplantation 1997; 64: 365-368.
24. Satoi S, Bramhall SR, Solomon M et al. The use of liver grafts from donors with bacterial meningitis. Transplantation 2001; 72: 1108-1113.
25. Anderson CB, Haid SD, Hruska KA, Etheredge EA. Significance of microbial contamination of stored cadaver kidneys. Arch Surg 1978; 113: 269-271.
26. Kumar D, Cattral MS, Robiscek A, Gaudreau C, Humar A. Outbreak of Pseudomonas aeruginosa by multiple organ transplantation from a common donor. Transplantation 2003; 75: 1053-1055.
27. Peters TG, Reiter CG, Boswell RL. Transmission of tuberculosis by kidney transplantation. Transplantation 1984; 38: 514-516.
28. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis 1998; 27: 1266-1277.
29. Antony SJ, Ynares C, Dummer JS. Isoniazid hepatotoxicity in renal transplant recipients. Clin Transplant 1997; 11: 34-37.
30. Limaye AP, Connolly PA, Sagar M et al. Transmission of Histoplasma capsulatum by organ transplantation. N Engl J Med 2000; 343: 1163-1166.
31. Tripathy U, Yung GL, Kriett JM, Thistlethwaite PA, Kapelanski DP, Jamieson SW. Donor transfer of pulmonary coccidioidomycosis in lung transplantation. Ann Thorac Surg 2002; 73: 306-308.
32. Blair JE, Logan JL. Coccidioidomycosis in solid organ transplantation. Clin Infect Dis 2001; 33: 1536-1544.
33. McGregor CG, Fleck DG, Nagington J, Stovin PG, Cory-Pearce R, English TA. Disseminated toxbplasmosis in cardiac transplantation. J Clin Pathol 1984; 37: 74-77.
34. Mayes JT, O'Connor BJ, Avery R, Castellani W, Carey W. Transmission of Toxoplasma gondii infection by liver transplantation. Clin Infect Dis 1995; 21: 511-515.
35. Renoult E, Georges E, Biava MF et al. Toxoplasmosis in kidney transplant recipients: report of six cases and review. Clin Infect Dis 1997; 24: 625-634.
36. Wreghitt TG, Gray JJ, Pavel P et al. Efficacy of pyrimethamine for the prevention of donor-acquired Toxoplasma gondii infection in heart and heart-lung transplant patients. Transpl Int 1992; 5: 197-200.
37. Chagas disease after organ transplantation - United States, 2001. MMWR Morb Mortal Wkly Report 2002; 51: 210-212.
38. Falagas ME, Snydman DR, Griffith J, Ruthazer R, Werner BG. Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG Study Group. Ann Intern Med 1997; 126: 275-279.
39. Falagas ME, Snydman DR, Griffith J, Werner BG, Freeman R, Rohrer R. Clinical and epidemiological predictors of recurrent cytomegalovirus disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study Group. Clin Infect Dis 1997; 25: 314-317.
40. Limaye AP, Corey L, Koelle DM, Davis CL, Boeckh M. Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants. Lancet 2000; 356: 645-649.
41. Patel R, Snydman DR, Rubin RH et al. Cytomegalovirus prophylaxis in solid organ transplant recipients. Transplantation 1996; 61: 1279-1289.
42. Preiksaitis JK, Keay S. Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients. Clin Infect Dis 2001; 33 (Suppl. 1): S38-S46.
43. Green M, Cacciarelli TV, Mazariegos GV et al. Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease. Transplantation 1998; 66: 1641-1644.
44. McDiarmid SV, Jordan S, Kim GS et al. Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients. Transplantation 1998; 66: 1604-1611.
45. Lynfield R, Herrin JT, Rubin RH. Varicella in pediatric renal transplant recipients. Pediatrics 1992; 90: 216-220.
46. DesJardin JA, Gibbons L, Cho E et al. Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection. J Infect Dis 1998; 178: 1783-1786.
47. Dockrell DH, Mendez JC, Jones M et al. Human herpesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipients. Transplantation 1999; 67: 399-403.
48. Mendez JC, Procop GW, Espy MJ, Smith TF, McGregor CG, Paya CV. Relationship of HHV8 replication and Kaposi's sarcoma after solid organ transplantation. Transplantation 1999; 67: 1200-1201.
49. Regamey N, Tamm M, Binet I, Thiel G, Erb P, Cathomas G. Transplantation-associated Kaposi's sarcoma: herpesvirus 8 transmission through renal allografts. Transplant Proc 1999; 31: 922-923.
50. Gomez-Roman JJ, Ocejo-Vinyals JG, Sanchez-Velasco P, Leyva-Cobian F, Val-Bernal JF. Presence of human herpesvirus 8 DNA sequences in renal transplantation-associated pleural Kaposi sarcoma. Arch Pathol Laboratory Med 1999; 123: 1269-1273.
51. Kapelushnik J, Ariad S, Benharroch D et al. Post renal transplantation human herpesvirus 8-associated lymphoproliferative disorder and Kaposi's sarcoma. Br J Haematol 2001; 113: 425-428.
52. Wachs ME, Amend WJ, Ascher NL et al. The risk of transmission of hepatitis B from HBsAg (-), HBcAb (+), HBIgM (-) organ donors. Transplantation 1995; 59: 230-234.
53. Dodson SF, Bonham CA, Geller DA, Cacciarelli W, Rakela J, Fung JJ. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors. Transplantation 1999; 68: 1058-1061.
54. Madayag RM, Johnson LB, Bartlett ST et al. Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease. Transplantation 1997; 64: 781-1786.
55. Van Thiel DH, el-Ashmawy L, Love K, Gavaler JS, Starzl TE. Response to hepatitis B vaccination by liver transplant candidates. Dig Dis Sci 1992; 37: 1245-1249.
56. McGory RW, Ishitani MB, Oliveira WM et al. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation 1996; 61: 1358-1364.
57. Younossi ZM, Braun WE, Protiva DA, Gifford RW Jr, Straffon RA. Chronic viral hepatitis in renal transplant recipients with allografts functioning for more than 20 years. Transplantation 1999; 67: 272-275.
58. Lee WC, Wu MJ, Cheng CH, Chen CH, Shu KH, Lian JD. Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients. Am J Kidney Dis 2001; 38: 1074-1081.
59. Ghobrial RM, Farmer DG, Baquerizo A et al. Orthotopic liver transplantation for hepatitis C. Outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience. Ann Surg 1999; 229: 824-831; discussion 831-823.
60. Pereira BJ, Natov SN, Bouthot BA et al. Effects of Hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group. Kidney Int 1998; 53: 1374-1381.
61. Fishman JA, Rubin RH, Koziel MJ, Periera BJ. Hepatitis C virus and organ transplantation. Transplantation 1996; 62: 147-154.
62. Everhart JE, Wei Y, Eng H et al. Recurrent and new Hepatitis C virus infection after liver transplantation. Hepatology 1999; 29: 1220-1226.
63. Ali MK, Light JA, Barhyte DY et al. Donor Hepatitis C virus status does not adversely affect short-term outcomes in HCV+ recipients in renal transplantation. Transplantation 1998; 66: 1694-1697.
64. Shah G, Demetris AJ, Irish W, Scheffel J, Mimms L, Van Thiel DH. Frequency and severity of HCV infection following orthotopic liver transplantation. Effect of donor and recipient serology for HCV using a second generation ELISA test. J Hepatol 1993; 18: 279-283.
65. Coller SJ, Jensen DM, Kesten S. Hepatitis C virus infection and lung transplantation, a survey of practices. J Heart Lung Transplant 1999; 18: 456-459.
66. Lake KD, Smith CI, LaForest SK, Allen J, Pritzker MR, Emery RW. Policies regarding the transplantation of hepatitis C-positive candidates and donor organs. J Heart Lung Transplant 1997; 16: 917-921.
67. Ong JP, Barnes DS, Younossi ZM et al. Outcome of de novo Hepatitis C virus infection in heart transplant recipients. Hepatology 1999; 30: 1293-1298.
68. Kuo PC. Reconsideration of HIV as a contraindication to transplantation. Transplantation 2001; 71: 1689.
69. Gow PJ, Pillay D, Mutimer D. Solid organ transplantation in patients with HIV infection. Transplantation 2001; 72: 177-181.
70. Fishman JA, Rubin RH. Solid organ transplantation in HIV-infected individuals: obstacles and opportunities. Transplant Proc 2001; 33: 1310-1314.
71. Guidelines for counseling persons infected with human T-lymphotropic virus type I (HTLV-I) and type II (HTLV-II). Centers for Disease Control and Prevention and the USPHS Working Group. Ann Intern Med 1993; 118: 448-454.
72. Tanabe K, Kitani R, Takahashi K et al. Long-term results in human T-cell leukemia virus type 1-positive renal transplant recipients. Transplant Proc 1998; 30: 3168-3170.
73. Update: Investigations of West Nile virus infections in recipients of organ transplantation and blood transfusion. MMWR Morb Mortal Wkly Report 2002; 51: 833-836.
74. Update: Investigations of West Nile virus infections in recipients of organ transplantation and blood transfusion - Michigan, 2002. MMWR Morb Mortal Wkly Report 2002; 51: 879.
75. Rubin J, Ray R, Barnes T et al. Peritonitis in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 1983; 2: 602-609.
76. Tolkoff-Rubin NE, Rubin RH. New approaches to the treatment of urinary tract infection. Am J Med 1987; 82: 270-277.
77. McCarthy PM, Schmitt SK, Vargo RL, Gordon S, Keys TF, Hobbs RE. Implantable LVAD infections: implications for permanent use of the device. Ann Thorac Surg 1996; 61: 359-365; discussion 372-353.
78. Schmitt SK, Serkey JM, Gordon SM et al. Impact of newer medical devices on nosocomial infection surveillance: etiologic fraction of bloodstream infections in patients with implantable left ventricular devices in a cardiothoracic intensive care unit. Paper Presented at Society for Healthcare Epidemiology of America, 8th Annual Meeting, 1998.
79. Holman WL, Skinner JL, Waites KB, Benza RL, McGiffin DC, Kirklin JK. Infection during circulatory support with ventricular assist devices. Ann Thorac Surg 1999; 68: 711-716.
80. Argenziano M, Catanese KA, Moazami N et al. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. J Heart Lung Transplant 1997; 16: 822-831.
81. Herrmann M, Weyand M, Greshake B et al. Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation. Circulation 1997; 95: 814-817.
82. Myers TJ, Khan T, Frazier OH. Infectious complications associated with ventricular assist systems. Asaio J 2000; 46: S28-S36.
83. Springer WE, Wasler A, Radovancevic B et al. Retrospective analysis of infection in patients undergoing support with left ventricular assist systems. ASAIO J 1996; 42: M763-M765.
84. LiPuma JJ. Expanding microbiology of pulmonary infection in cystic fibrosis. Pediatr Infect Dis J 2000; 19: 473-474.
85. Li PJ, Spilker T, Gill LH, Campbell PW, 3rd Liu L, Mahenthiralingam E. Disproportionate Distribution of Burkholderia cepacia Complex Species and Transmissibility Markers in Cystic Fibrosis. Am J Respir Crit Care Med 2001; 164: 92-96.
86. LiPuma JJ. Burkholderia cepacia complex: a contraindication to lung transplantation in cystic fibrosis? Transpl Infect Dis 2001; 3: 149-160.
87. Gordon SM, Avery RK. Aspergillosis in lung transplantation: incidence, risk factors, and prophylactic strategies. Transpl Infect Dis 2001; 3: 161-167.
88. Avery RK. Immunizations in adult immunocompromised patients: which to use and which to avoid. Cleve Clin J Med 2001; 68: 337-348.
89. Pirofski LA, Casadevall A. Use of licensed vaccines for active immunization of the immunocompromised host. Clin Microbiol Rev 1998; 11: 1-26.
90. Burroughs M, Moscona A. Immunization of pediatric solid organ transplant candidates and recipients. Clin Infect Dis 2000; 30: 857-869.
91. Keeffe E. Hepatitis A in patients with chronic liver disease - severity of illness and prevention with vaccination. J Viral Hepat 2000; 7 (Suppl. 1): 15-17.
92. Dumot JA, Barnes DS, Younossi Z et al. Immunogenicity of hepatitis A vaccine in decompensated liver disease. Am J Gastroenterol 1999; 94: 1601-1604.